Rappuoli R - Search Results

1

The challenges of vaccinating the very young: lessons from a very old system of host defense.

Valiante NM, Rappuoli R, Insel RA, McInnes P, Hoeveler A. Valiante NM, et al. Among authors: rappuoli r. Vaccine. 1999 Jul 16;17(22):2757-62. doi: 10.1016/s0264-410x(99)00027-4. Vaccine. 1999. PMID: 10438043 No abstract available.

2

Progress towards the development of new vaccines against whooping cough.

Rappuoli R, Podda A, Pizza M, Covacci A, Bartoloni A, de Magistris MT, Nencioni L. Rappuoli R, et al. Vaccine. 1992;10(14):1027-32. doi: 10.1016/0264-410x(92)90112-w. Vaccine. 1992. PMID: 1471424 Review.

3

Immunity to Haemophilus influenzae type b on sample population from central Italy.

Sansoni A, Rappuoli R, Viti S, Costantino P, Fanti O, Cellesi C. Sansoni A, et al. Among authors: rappuoli r. Vaccine. 1992;10(9):627-30. doi: 10.1016/0264-410x(92)90445-p. Vaccine. 1992. PMID: 1502841

4

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C.

Costantino P, Viti S, Podda A, Velmonte MA, Nencioni L, Rappuoli R. Costantino P, et al. Among authors: rappuoli r. Vaccine. 1992;10(10):691-8. doi: 10.1016/0264-410x(92)90091-w. Vaccine. 1992. PMID: 1523880 Clinical Trial.

5

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.

Podda A, Nencioni L, Marsili I, Peppoloni S, Volpini G, Donati D, Di Tommaso A, De Magistris MT, Rappuoli R. Podda A, et al. Among authors: rappuoli r. Vaccine. 1991 Oct;9(10):741-5. doi: 10.1016/0264-410x(91)90290-m. Vaccine. 1991. PMID: 1759492 Clinical Trial.

6

Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.

Bartoloni A, Norelli F, Ceccarini C, Rappuoli R, Costantino P. Bartoloni A, et al. Among authors: rappuoli r. Vaccine. 1995 Apr;13(5):463-70. doi: 10.1016/0264-410x(94)00007-a. Vaccine. 1995. PMID: 7543714

7

Toxin inactivation and antigen stabilization: two different uses of formaldehyde.

Rappuoli R. Rappuoli R. Vaccine. 1994 May;12(7):579-81. doi: 10.1016/0264-410x(94)90259-3. Vaccine. 1994. PMID: 8085372 Review.

8

Absence of protective immunity against diphtheria in a large proportion of young adults.

Rappuoli R, Podda A, Giovannoni F, Nencioni L, Peragallo M, Francolini P. Rappuoli R, et al. Vaccine. 1993;11(5):576-7. doi: 10.1016/0264-410x(93)90235-p. Vaccine. 1993. PMID: 8488714

9

Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.

Di Tommaso A, Bartalini M, Peppoloni S, Podda A, Rappuoli R, De Magistris MT. Di Tommaso A, et al. Among authors: rappuoli r. Vaccine. 1997 Aug;15(11):1218-24. doi: 10.1016/s0264-410x(97)00023-6. Vaccine. 1997. PMID: 9286047 Clinical Trial.

10

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

Marchetti M, Rossi M, Giannelli V, Giuliani MM, Pizza M, Censini S, Covacci A, Massari P, Pagliaccia C, Manetti R, Telford JL, Douce G, Dougan G, Rappuoli R, Ghiara P. Marchetti M, et al. Among authors: rappuoli r. Vaccine. 1998 Jan;16(1):33-7. doi: 10.1016/s0264-410x(97)00153-9. Vaccine. 1998. PMID: 9607006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

818 results

Search Page

Filters